Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target.
J Med Chem
; 63(2): 638-655, 2020 01 23.
Article
in En
| MEDLINE
| ID: mdl-31855425
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Class I Phosphatidylinositol 3-Kinases
/
Class III Phosphatidylinositol 3-Kinases
/
Phosphoinositide-3 Kinase Inhibitors
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2020
Type:
Article